This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Immune Disease Institute, Inc., Industry-University Cooperation Foundation Hanyang University. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014
Title: Innovations of Hong-Seok Ban in RNA Delivery
Introduction
Hong-Seok Ban is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of molecular biology, particularly in the targeted delivery of RNA interference molecules. His innovative approach has the potential to advance therapeutic strategies in various medical applications.
Latest Patents
Hong-Seok Ban holds a patent for a method of delivering RNA interference molecules to a cell. This invention involves contacting the cell with a protein-double stranded RNA complex. The complex comprises a double stranded RNA segment containing a double stranded RNA of interest and a protein. The protein includes a targeting moiety that specifically binds to a site on a target cell, along with a binding moiety linked to it, which binds to the double stranded RNA. This method effectively delivers the double stranded RNA segment to a cell, facilitating RNA interference of the target RNA within the cell.
Career Highlights
Throughout his career, Hong-Seok Ban has worked with various institutions, including the Industry-University Cooperation Foundation at Hanyang University and the Immune Disease Institute, Inc. His work has been instrumental in bridging the gap between academic research and practical applications in the biotechnology sector.
Collaborations
Hong-Seok Ban has collaborated with notable colleagues such as Premlata Shankar and Sang-Kyung Lee. These partnerships have contributed to the advancement of research in RNA delivery systems and their applications in medicine.
Conclusion
Hong-Seok Ban's innovative work in the field of RNA delivery showcases the potential of targeted therapies in modern medicine. His contributions continue to influence research and development in biotechnology, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile